WANBURY LIMITED (WANBURY) financials

WANBURY LIMITED (WANBURY) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Incorporated in 1988, Wanbury Ltd is in the business of pharmaceutical and related activities, including research[1]

Market Cap: ₹677Cr.
Current Price: ₹193
Stock P/E: 11.4
ROE: 68.4%
ROCE: 30.7%
Book Value: ₹41.3
Dividend Yield: 0.00%
52W High / Low: ₹360/162

In Jun 2026, WANBURY LIMITED (WANBURY) reported sales ₹165.58 Cr and net profit ₹3.24 Cr.

Annual TTM: sales ₹653 Cr, net profit ₹56 Cr.

Shareholding: Promoters 43.01% (Jun 2026), FIIs 0.89% (Jun 2026), DIIs 0.06% (Jun 2026), Public 56.04% (Jun 2026), No. of Shareholders 17,174% (Jun 2026).

WANBURY quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	161.19	133.45	172.00	163.18	160.06	162.45	164.58	165.58
Expenses	141.18	119.50	142.37	138.74	134.28	135.77	134.74	149.35
Operating Profit	20.01	13.95	29.63	24.44	25.78	26.68	29.84	16.23
OPM %	12.41%	10.45%	17.23%	14.98%	16.11%	16.42%	18.13%	9.80%
Other Income	1.63	0.84	1.84	0.35	0.20	0.18	-3.39	0.36
Interest	10.15	10.17	9.04	7.54	7.12	7.26	8.06	7.97
Depreciation	3.32	3.32	3.37	3.64	3.70	3.74	3.23	4.04
Profit before tax	8.17	1.30	19.06	13.61	15.16	15.86	15.16	4.58
Tax %	1.84%	5.38%	-6.30%	0.88%	-0.13%	0.69%	-43.14%	29.26%
Net Profit	8.02	1.22	20.26	13.49	15.18	15.76	21.70	3.24
EPS in Rs	2.45	0.37	6.18	4.10	4.35	4.52	6.21	0.93
Raw PDF	—	—	—	—	—	—	—	—

WANBURY profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	367	392	511	500	578	600	650	653
Expenses	344	374	475	476	506	523	544	554
Operating Profit	23	18	36	23	72	77	107	99
OPM %	6%	4.7%	7%	4.7%	12%	13%	16%	15%
Other Income	84	2	77	0	1	3	-3	-3
Interest	33	23	21	21	29	37	30	30
Depreciation	10	10	11	12	13	13	14	15
Profit before tax	65	-12	81	-10	31	30	60	51
Tax %	0%	2%	-0%	1%	1%	-3%	-11%	—
Net Profit	64	-13	81	-10	30	31	66	56
EPS in Rs	25.79	-5.04	24.94	-3.18	9.28	9.32	18.93	16.01
Dividend Payout %	0%	0%	0%	0%	0%	0%	0%	—

WANBURY balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	24	25	25	33	33	33	33	35
Reserves	-207	-143	-156	-30	-40	-5	26	110
Borrowings	233	164	166	74	68	116	179	226
Other Liabilities	235	231	253	275	241	199	176	147
Total Liabilities	285	277	288	351	302	343	414	518
Fixed Assets	172	164	167	167	167	167	201	229
CWIP	9	14	11	2	2	3	5	25
Investments	0	0	0	0	0	0	0	0
Other Assets	103	99	109	182	133	173	208	263
Total Assets	285	277	288	351	302	343	414	518

WANBURY cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	30	44	17	41	20	5	26	32
Cash from Investing Activity	-3	64	8	1	-9	-17	-51	-56
Cash from Financing Activity	-27	-108	-17	-29	-32	14	26	22
Net Cash Flow	-0	-0	7	13	-21	2	1	-2
Free Cash Flow	25	36	12	42	7	-9	-22	-28
CFO/OP	188%	188%	97%	113%	86%	7%	35%	30%

WANBURY shareholding pattern (%)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoters	39.77%	39.76%	39.76%	39.63%	43.09%	43.08%	43.01%	43.01%
FIIs	1.02%	0.84%	1.55%	1.59%	0.82%	0.72%	0.59%	0.89%
DIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.06%
Public	59.21%	59.40%	58.68%	58.79%	56.08%	56.21%	56.39%	56.04%
No. of Shareholders	17,199	17,999	17,889	17,894	17,717	17,261	16,732	17,174

WANBURY key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	41	50	32	45	50	56	70	80
Inventory Days	36	25	41	60	26	43	47	67
Days Payable	208	252	220	218	178	196	172	142
Cash Conversion Cycle	-131	-176	-147	-112	-101	-96	-55	6
Working Capital Days	-230	-211	-227	-134	-129	-37	3	17
ROCE %	26%	31%	23%	46%	17%	58%	34%	31%

WANBURYUpdated 13 Oct 2026, 20:09

Wanbury Limited

WANBURYUpdated 13 Oct 2026, 20:09

Market Cap

₹677Cr.

Current Price

₹193

High / Low

₹360/162

Stock P/E

11.4

ROE68.4%

ROCE30.7%

Book Value₹41.3

Face Value₹10.0

Dividend Yield0.00%

About

Incorporated in 1988, Wanbury Ltd is in the business of pharmaceutical and related activities, including research[1]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	146.29	5.79	132.94	0.62	3.18	5	6	4.69	1.43
Sep 2023	144.46	7.67	127.12	0.76	3.24	7.19	-2.5	7.36	2.25
Dec 2023	145.5	8.26	124.35	0.69	3.32	10.26	-0.19	10.27	3.14
Mar 2024	139.41	7.46	121.25	0.93	3.28	8.35	3.23	8.08	2.47
Jun 2024	131.11	7.59	120.13	0.94	3.29	1.04	0	1.04	0.32
Sep 2024	161.19	10.15	141.18	1.63	3.32	8.17	1.84	8.02	2.45
Dec 2024	133.45	10.17	119.5	0.84	3.32	1.3	5.38	1.22	0.37
Mar 2025	172	9.04	142.37	1.84	3.37	19.06	-6.3	20.26	6.18
Jun 2025	163.18	7.54	138.74	0.35	3.64	13.61	0.88	13.49	4.1
Sep 2025	160.06	7.12	134.28	0.2	3.7	15.16	-0.13	15.18	4.35
Dec 2025	162.45	7.26	135.77	0.18	3.74	15.86	0.69	15.76	4.52
Mar 2026	164.58	8.06	134.74	-3.39	3.23	15.16	-43.14	21.7	6.21
Jun 2026	165.58	7.97	149.35	0.36	4.04	4.58	29.26	3.24	0.93

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015 6m	250	19	228	6	5	4	28	3	1.61
Mar 2016	420	32	387	0	9	-7	0	-7	-3.52
Mar 2017	432	36	414	90	10	62	1	62	26.71
Mar 2018	370	31	438	76	10	-32	-1	-32	-13.49
Mar 2019	391	40	375	9	10	-25	-1	-25	-10.48
Mar 2020	367	33	344	84	10	65	0	64	25.79
Mar 2021	392	23	374	2	10	-12	2	-13	-5.04
Mar 2022	511	21	475	77	11	81	0	81	24.94
Mar 2023	500	21	476	0	12	-10	1	-10	-3.18
Mar 2024	578	29	506	1	13	31	1	30	9.28
Mar 2025	600	37	523	3	13	30	-3	31	9.32
Mar 2026	650	30	544	-3	14	60	-11	66	18.93
TTM	653	30	554	-3	15	51	—	56	16.01

Shareholding pattern

As of Jun 2026%

Holder	Share
Promoters	43.01%
FIIs	0.89%
DIIs	0.06%
Public	56.04%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Sep 2023	39.8%	0%	0%	60.19%
Dec 2023	39.79%	0%	0%	60.2%
Mar 2024	39.79%	0.18%	0%	60.02%
Jun 2024	39.79%	0.22%	0%	59.97%
Sep 2024	39.77%	1.02%	0%	59.21%
Dec 2024	39.76%	0.84%	0%	59.4%
Mar 2025	39.76%	1.55%	0%	58.68%
Jun 2025	39.63%	1.59%	0%	58.79%
Sep 2025	43.09%	0.82%	0%	56.08%
Dec 2025	43.08%	0.72%	0%	56.21%
Mar 2026	43.01%	0.59%	0%	56.39%
Jun 2026	43.01%	0.89%	0.06%	56.04%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Other Assets	Total Assets
Mar 2015	20	-188	381	182	394	164	19	212	394
Mar 2016	20	-183	373	176	386	180	14	192	386
Mar 2017	23	-151	273	265	411	186	10	215	411
Mar 2018	24	-183	224	207	271	178	10	83	271
Mar 2019	24	-207	233	235	285	172	9	103	285
Mar 2020	25	-143	164	231	277	164	14	99	277
Mar 2021	25	-156	166	253	288	167	11	109	288
Mar 2022	33	-30	74	275	351	167	2	182	351
Mar 2023	33	-40	68	241	302	167	2	133	302
Mar 2024	33	-5	116	199	343	167	3	173	343
Mar 2025	33	26	179	176	414	201	5	208	414
Mar 2026	35	110	226	147	518	229	25	263	518

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	40	-5	-30	5
Mar 2016	43	-20	-28	-5
Mar 2017	43	-13	-27	3
Mar 2018	32	-1	-33	-2
Mar 2019	30	-3	-27	0
Mar 2020	44	64	-108	0
Mar 2021	17	8	-17	7
Mar 2022	41	1	-29	13
Mar 2023	20	-9	-32	-21
Mar 2024	5	-17	14	2
Mar 2025	26	-51	26	1
Mar 2026	32	-56	22	-2

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	144	65	71	29	41	50	32	45	50	56	70	80
Inventory Days	103	69	63	27	36	25	41	60	26	43	47	67
Days Payable	300	171	259	173	208	252	220	218	178	196	172	142
Cash Conversion Cycle	-54	-37	-124	-117	-131	-176	-147	-112	-101	-96	-55	6
Working Capital Days	-139	-123	-164	-251	-230	-211	-227	-134	-129	-37	3	17
ROCE %	—	12%	55%	-1%	26%	31%	23%	46%	17%	58%	34%	31%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of WANBURY LIMITED (WANBURY)?

The reported market capitalisation for WANBURY LIMITED (WANBURY) is ₹677Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of WANBURY?

The current price shown for WANBURY LIMITED (WANBURY) on Fincrux is ₹193 with a 52-week high/low of ₹360/162.

What is the P/E ratio of WANBURY LIMITED (WANBURY)?

The stock P/E for WANBURY LIMITED (WANBURY) is 11.4 on Fincrux, with ROE at 68.4% and ROCE at 30.7%.

What were WANBURY latest quarterly results?

For Jun 2026, WANBURY LIMITED (WANBURY) reported sales ₹165.58 Cr and net profit ₹3.24 Cr (figures in ₹ crore unless noted).

What are WANBURY annual sales and net profit?

For TTM, WANBURY LIMITED (WANBURY) shows sales of ₹653 Cr and net profit of ₹56 Cr on the Fincrux profit & loss statement.

Who owns WANBURY LIMITED (WANBURY)?

Latest shareholding for WANBURY LIMITED (WANBURY) on Fincrux: Promoters 43.01% (Jun 2026), FIIs 0.89% (Jun 2026), DIIs 0.06% (Jun 2026), Public 56.04% (Jun 2026), No. of Shareholders 17,174% (Jun 2026).

Where can I find WANBURY LIMITED (WANBURY) financials?

WANBURY LIMITED (WANBURY) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show WANBURY balance sheet and cash flow?

Yes. The WANBURY LIMITED (WANBURY) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 13 October 2026 at 20:09